RELAPSED/REFRACTORY WALDENSTROM MACROGLOBULINEMIA

Clinical trials for RELAPSED/REFRACTORY WALDENSTROM MACROGLOBULINEMIA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY WALDENSTROM MACROGLOBULINEMIA trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY WALDENSTROM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental cell therapy tested as last hope for rare cancers

Disease control Terminated

This study tested an experimental cell therapy called brexucabtagene autoleucel in adults with rare and aggressive types of B-cell blood cancers that had returned or stopped responding to standard treatments. The therapy, known as CAR-T, involves genetically modifying a patient's…

Matched conditions: RELAPSED/REFRACTORY WALDENSTROM MACROGLOBULINEMIA

Phase: PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

RELAPSED/REFRACTORY WALDENSTROM MACROGLOBULINEMIA

Get alerted when new RELAPSED/REFRACTORY WALDENSTROM MACROGLOBULINEMIA trials appear

Experimental cell therapy tested as last hope for rare cancers